This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Small cell lung cancer, helper endpoint
HLP_C3_SCLC
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1005 |
4. Check minimum number of eventsNone |
1005 |
5. Include endpointsNone |
1005 |
6. Filter based on genotype QC (FinnGen only) |
970 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Small cell lung cancer, helper endpoint
based on the number of shared cases.
Similar with more cases:
- Small cell lung cancer, including Hilmo
- Small cell lung cancer
- Malignant neoplasm of bronchus and lung
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of bronchus and lung, including Hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 970 | 226 | 744 |
| Unadjusted period prevalence (%) | 0.28 | 0.08 | 0.34 |
| Median age at first event (years) | 70.95 | 68.89 | 71.57 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1005
- Matched controls
- 10050
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
38.5
321.1
204
66
H02AB02
ATC
dexamethasone; systemic
11.6
311.5
422
591
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
27.0
307.7
292
150
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
307.7
635
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
867.7
307.7
305
5
L01CB01
ATC
etoposide; systemic
219.0
307.7
272
17
130
Kela drug reimbursment
Malignant tumour
17.3
307.7
560
683
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.2
271.2
398
607
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
560.1
231.0
221
5
A03FA01
ATC
metoclopramide; systemic, rectal
7.3
220.8
527
1322
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
12.2
213.6
240
252
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.7
210.5
401
798
WF049
NOMESCO Finland
Radiotherapy of metastasis
14.0
201.9
202
177
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
18.9
188.2
156
97
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
179.7
167
*
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
687.2
179.4
172
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.5
178.1
204
218
A04AA01
ATC
ondansetron; systemic, rectal
8.7
163.5
238
345
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
17.0
154.8
134
90
WF004
NOMESCO Finland
Palliative radiotherapy
14.5
150.1
143
114
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
28.7
148.0
101
39
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
16.4
138.8
122
84
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
43.0
137.6
83
21
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
+∞
118.1
111
*
Z51.5
ICD-10 Finland
Palliative care
5.8
117.4
260
570
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
386.3
106.4
105
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
12.2
101.1
105
95
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
1070.8
101.0
97
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
33.5
93.1
60
19
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
23.2
75.2
55
25
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
19.8
74.0
58
31
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
11.1
72.9
80
78
TGD00
NOMESCO Finland
Needle biopsy of lung
29.6
71.7
48
17
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
10.8
70.7
79
79
N02AA05
ATC
oxycodone; systemic
3.4
69.5
364
1452
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
35.4
69.4
44
13
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.2
68.4
108
166
R84
ICPC
Malignant neoplasm bronchus/lung
27.3
68.3
47
18
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.7
65.4
79
88
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
25.7
59.8
42
17
8041/3-C34.0
ICD-O-3
Small cell carcinoma, NOS, of main bronchus
+∞
53.6
51
*
A98
ICPC
Health maint/preventive medicine
0.4
51.0
430
6712
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
12.2
49.3
50
43
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
6.5
48.9
83
137
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
12.2
48.4
49
42
A04AA55
ATC
palonosetron, combinations; systemic
7.8
47.5
68
93
C34.26
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma
+∞
46.2
44
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.3
45.7
52
53
L03AA13
ATC
pegfilgrastim; parenteral
5.8
44.8
86
160
A04AA02
ATC
granisetron; systemic, transdermal
4.4
44.0
119
297
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
16.7
43.7
37
23
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
10.5
42.7
48
48
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.3
41.2
72
122
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.7
40.7
285
1281
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.0
40.4
125
344
8041/3-C34.2
ICD-O-3
Small cell carcinoma, NOS, of middle lobe, lung
+∞
38.8
37
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
5.7
38.4
74
138
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
9.7
36.4
43
46
XX3DW
NOMESCO Finland
Time consuming IT work
3.2
35.6
164
584
WF002
NOMESCO Finland
Radical radiotherapy
3.8
33.0
110
318
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
7.2
31.6
48
70
L01XX17
ATC
[U] topotecan
+∞
31.4
30
*
1623B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MICROCELLURE]
165.1
30.9
32
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
6.5
29.4
49
79
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.7
29.2
47
73
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.4
28.7
111
353
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.6
28.3
101
305
L03AA14
ATC
lipegfilgrastim; parenteral
8.3
27.9
37
46
N40
ICD-10 Finland
Hyperplasia of prostate
0.3
27.8
124
2884
N07BA03
ATC
varenicline; oral
5.5
26.3
52
99
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
6.6
26.2
43
68
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
9.6
24.5
29
31
L01CE01
ATC
topotecan; systemic
+∞
23.0
22
*
N06DX01
ATC
memantine; oral
0.1
22.4
7
745
JN4BD
NOMESCO Finland
Extensive body CT
2.5
21.9
154
676
1625B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA MICROCELLURE]
224.7
21.7
22
*
ZX080
NOMESCO Finland
Image guided radiotherapy
5.5
21.0
41
77
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.1
21.0
45
92
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.1
20.8
58
147
I10
ICD-10 Finland
Essential (primary) hypertension
0.5
20.6
372
5302
G04CA02
ATC
tamsulosin; oral
0.4
19.9
165
3062
A06AH03
ATC
naloxegol; oral
6.3
19.5
33
54
N02BE01
ATC
paracetamol; systemic, rectal
0.5
19.3
541
6850
R03BB04
ATC
tiotropium bromide; inhalant
2.2
19.1
192
982
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.4
19.0
148
679
SAA02
NOMESCO Finland
Basic examination of mouth
0.5
18.8
189
3293
JN4AD
NOMESCO Finland
Body CT examination
2.5
18.7
133
586
WW200, ,
SPAT
0.2
18.3
21
1114
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.2
18.2
38
76
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
18.2
81
280
J01DB01
ATC
cefalexin; oral
0.6
17.9
455
5999
SFA20
NOMESCO Finland
Two-surface restoration
0.5
17.0
157
2841
N02AA01
ATC
morphine; systemic, rectal
4.0
16.9
49
128
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.3
16.9
67
216
SAA01
NOMESCO Finland
Simple examination of mouth
0.5
16.6
248
3844
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.1
16.5
15
948
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.5
16.4
32
60
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.9
16.2
25
37
H25.1
ICD-10 Finland
Senile nuclear cataract
0.5
16.2
154
2771
L03AA02
ATC
filgrastim; parenteral
4.0
16.1
46
119
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
6.0
15.8
28
48
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
15.6
199
3258
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
22.5
15.6
22
10
A04AD12
ATC
aprepitant; systemic
5.6
15.3
29
53
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
20.4
15.1
22
11
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.0
15.1
43
111
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
32.2
14.8
19
6
N06DA02
ATC
donepezil; oral
0.1
14.6
7
547
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
14.4
14.6
24
17
H02AB06
ATC
prednisolone; systemic
1.7
14.3
477
3515
M01AH05
ATC
etoricoxib; oral
0.5
14.2
216
3380
SFA10
NOMESCO Finland
One-surface restoration
0.5
14.0
161
2749
S18
ICPC
Laceration/cut
0.5
14.0
184
3012
P20
ICPC
Memory disturbance
0.3
14.0
36
1165
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.5
13.9
107
2102
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
14.0
13.3
22
16
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.7
13.2
72
278
C10AA05
ATC
atorvastatin; oral
0.5
13.1
207
3227
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
0.5
13.1
170
2805
ZX095
NOMESCO Finland
Combined chemoradiotherapy
9.8
12.8
25
26
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.4
12.7
71
1589
1628B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA MICROCELLURE]
+∞
12.5
12
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.8
12.5
38
103
M79.6
ICD-10 Finland
Pain in limb
0.5
12.4
127
2270
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
0.5
12.3
181
2894
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
12.3
387
2777
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.3
12.2
42
1173
M25.5
ICD-10 Finland
Pain in joint
0.4
12.1
60
1417
I87.1
ICD-10 Finland
Compression of vein
47.2
11.9
14
*
XKD00
NOMESCO Finland
Uroflowmetry
0.4
11.8
76
1608
SDA03
NOMESCO Finland
Periodontal treatment
0.4
11.7
84
1706
K02.1
ICD-10 Finland
Caries of dentine
0.6
11.6
184
2890
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
23.2
11.6
16
7
SFA30
NOMESCO Finland
Three-surface restoration
0.5
11.5
115
2082
Z01.2
ICD-10 Finland
Dental examination
0.5
11.5
109
2005
WX110
NOMESCO Finland
Infiltration anesthesia
0.6
11.4
304
4180
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
10.7
11.3
21
20
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
9.8
11.3
22
23
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.5
11.3
144
2412
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.3
11.2
30
958
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.6
11.1
169
2694
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.4
11.1
74
1550
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
11.1
126
2189
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
11.0
56
1312
SPAT1325
SPAT
Vaccination
0.5
10.9
143
2379
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
28.4
10.7
14
5
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.4
10.7
76
1558
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
13.1
10.7
18
14
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.1
10.6
104
521
G04CB01
ATC
finasteride; oral
0.4
10.6
75
1540
UKC02
NOMESCO Finland
Cystoscopy
0.5
10.6
78
1578
Z72.0
ICD-10 Finland
Tobacco use
4.0
10.4
29
74
WW500
NOMESCO Finland
Blood transfusion
2.7
10.3
56
216
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
10.7
10.3
19
18
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
10.2
12
634
G04CB02
ATC
dutasteride; oral
0.3
10.0
23
800
G04BD12
ATC
mirabegron; oral
0.2
10.0
18
723
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.0
10.0
43
146
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
4.2
9.9
26
63
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.7
9.8
51
192
N03AX14
ATC
levetiracetam; systemic
3.4
9.8
34
101
G04CA01
ATC
alfuzosin; oral
0.4
9.8
57
1265
D19
ICPC
Teeth/gum symptom/complaint
0.4
9.7
47
1128
L08
ICPC
Shoulder symptom/complaint
0.4
9.7
43
1073
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.4
9.7
56
1248
GEA00
NOMESCO Finland
Mediastinoscopy
13.5
9.7
16
12
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.4
9.6
46
1109
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
9.5
50
1160
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
0.3
9.5
22
764
1622B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA MICROCELLURE]
+∞
9.4
9
*
L57.0
ICD-10 Finland
Actinic keratosis
0.3
9.4
23
772
TQW40, ,
SPAT
0.1
9.4
*
294
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
8.1
9.4
20
25
H02
ICPC
Hearing complaint
0.3
9.3
34
927
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.5
9.2
67
1368
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
13.8
9.2
15
11
SPAT1312
SPAT
General health counselling
0.5
9.2
89
1642
C10AA07
ATC
rosuvastatin; oral
0.5
9.1
104
1819
Z71.8
ICD-10 Finland
Other specified counselling
0.5
9.1
73
1436
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.2
8.9
17
661
EB1VA, ,
NOMESCO Finland
0.2
8.9
6
371
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.4
8.8
39
977
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.0
8.8
38
129
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
8.8
273
1922
L82
ICD-10 Finland
Seborrhoeic keratosis
0.4
8.7
37
944
WX290
NOMESCO Finland
Other blockage of nerve
0.5
8.7
114
1917
SPAT1053
SPAT
Memory test
0.4
8.6
58
1221
TGA30
NOMESCO Finland
Thoracocentesis
4.8
8.6
19
40
1240
FHL
Bronchoscopy
3.2
8.6
33
105
L17
ICPC
Foot/toe symptom/complaint
0.5
8.5
85
1556
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
27.8
8.5
11
*
R85
ICPC
Malignant neopl respiratory other
20.2
8.5
12
6
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.4
8.4
50
1106
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
90.8
8.4
9
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
7.9
8.4
18
23
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
8.4
33
870
1624B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA MICROCELLURE]
+∞
8.3
8
*
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
10.9
8.3
15
14
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.5
8.3
92
1628
D82
ICPC
Teeth/gum disease
0.5
8.3
82
1505
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
8.2
105
1783
116
Kela drug reimbursment
Prostate cancer
0.3
8.2
24
734
OAB44, ,
SPAT
0.1
8.2
*
260
KMAK, ,
NOMESCO Finland
0.6
8.2
167
2501
H91.1
ICD-10 Finland
Presbycusis
0.2
8.2
13
564
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
22.2
8.0
11
5
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
8.0
192
2769
K03.64
ICD-10 Finland
Dental calculus supragingival
0.4
8.0
52
1109
M01AX05
ATC
glucosamine; oral
0.5
8.0
72
1365
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.5
7.9
77
1425
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.4
7.9
43
985
J01MA02
ATC
ciprofloxacin; systemic
0.6
7.8
222
3089
B01AF02
ATC
apixaban; oral
0.4
7.8
36
884
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
7.8
64
300
SPAT1043
SPAT
Audiometry
0.3
7.7
20
653
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.1
7.7
*
295
R04.2
ICD-10 Finland
Haemoptysis
2.4
7.6
54
237
L15
ICPC
Knee symptom/complaint
0.5
7.6
56
1142
R4110, ,
SPAT
0.2
7.5
8
374
J01MA14
ATC
moxifloxacin; systemic
1.9
7.5
97
538
C09CA01
ATC
losartan; oral
0.6
7.4
106
1748
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
7.4
8
369
E0000UV, ,
ATC
0.6
7.3
166
2437
H13
ICPC
Plugged feeling ear
0.5
7.3
67
1267
UJF32
NOMESCO Finland
Coloscopy
0.6
7.3
110
1787
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.7
7.2
22
60
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.4
7.2
31
785
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
10.1
7.0
13
13
R33
ICD-10 Finland
Retention of urine
0.4
6.9
42
921
Z51.0
ICD-10 Finland
Radiotherapy session
3.6
6.9
22
62
L28
ICPC
Limited function/disability (L)
0.5
6.9
73
1317
WX320
NOMESCO Finland
Spinalanesthesy
0.6
6.9
92
1548
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.9
6.8
31
109
C08CA01
ATC
amlodipine; oral
0.7
6.8
222
3021
Z96.1
ICD-10 Finland
Presence of intraocular lens
0.5
6.8
66
1226
SCA01
NOMESCO Finland
Preventive oral health care, short
0.5
6.8
56
1098
Z00.0
ICD-10 Finland
General medical examination
0.5
6.8
62
1174
L13
ICPC
Hip symptom/complaint
0.5
6.8
49
1006
EB4VA, ,
NOMESCO Finland
0.1
6.8
*
269
L12
ICPC
Hand/finger symptom/complaint
0.4
6.7
26
693
A04AA03
ATC
tropisetron; systemic
12.3
6.6
11
9
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.4
6.6
41
891
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
0.2
6.6
10
445
K86
ICPC
Hypertension uncomplicated
0.4
6.5
32
765
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
6.5
545
6281
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
70.3
6.4
7
*
DAX08
NOMESCO Finland
Fitting of hearing aid
0.2
6.4
9
356
B01AF01
ATC
rivaroxaban; oral
0.4
6.4
36
814
C09CA06
ATC
candesartan; oral
0.5
6.3
69
1235
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
6.3
73
390
L01BC06
ATC
capecitabine; oral
0.1
6.3
*
188
J01EA01
ATC
trimethoprim; systemic
0.6
6.3
94
1536
L02AE02
ATC
leuprorelin; implant, parenteral
0.3
6.3
14
494
1629B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA MICROCELLURE]
+∞
6.3
6
*
SPAT1153
SPAT
Removal of sutures
0.6
6.2
136
2024
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
6.2
55
266
R31
ICD-10 Finland
Unspecified haematuria
0.5
6.2
50
989
A97
ICPC
No disease
0.5
6.2
46
937
SPAT1310
SPAT
Counselling related to known health issue
0.6
6.2
113
1756
OAB43, ,
SPAT
0.2
6.2
8
329
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
0.3
6.2
16
520
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
6.2
13
474
Y77
ICPC
Malignant neoplasm prostate
0.2
6.1
5
272
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
12.6
6.1
10
8
I50.9
ICD-10 Finland
Heart failure, unspecified
0.6
6.1
109
1701
K85
ICPC
Elevated blood pressure
0.5
6.1
50
981
A06AC01
ATC
ispaghula (psylla seeds); oral
0.6
6.1
109
1700
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.6
6.0
124
1874
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.3
6.0
14
484
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.6
6.0
104
1640
H91.9
ICD-10 Finland
Hearing loss, unspecified
0.2
6.0
6
289
J01FA06
ATC
roxithromycin; oral
1.4
6.0
340
2669
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
173
108
19.14
208.78
1.1
1.1
—
—
—
0
0
129
211
6.87
77.31
1.2
1.5
—
—
—
0
0
281
1159
2.98
48.21
4.2
3.2
0.77
0.82
mmol/l
8.07
271
1070
122
302
4.46
45.60
1.9
2.8
—
—
—
0
0
361
5896
0.39
42.83
5.8
6.5
42.26
41.26
mmol/mol
1.04
312
5307
391
6122
0.41
40.74
3.9
5.3
2.56
2.52
mmol/l
0.38
340
5462
375
5942
0.41
39.57
3.6
4.7
4.39
4.36
mmol/l
0.18
329
5344
369
5870
0.41
39.00
3.6
4.7
1.31
1.41
mmol/l
4.44
319
5221
395
6112
0.42
38.94
4.2
5.0
6.34
6.14
mmol/l
1.77
342
5387
81
163
5.32
38.67
1.2
1.3
—
—
—
0
0
480
6827
0.43
37.03
38.2
26.4
124.87
132.32
g/l
23.14
471
6643
480
6825
0.43
36.95
38.2
26.4
37.40
39.15
%
9.66
436
6230
480
6825
0.43
36.95
37.9
26.2
4.13
4.37
e12/l
20.58
463
6541
480
6824
0.43
36.91
38.0
26.2
254.68
234.29
e9/l
6.92
465
6570
481
6826
0.43
36.64
37.9
26.2
7.97
7.02
e9/l
10.43
464
6538
207
853
2.80
34.45
2.1
4.0
32.96
29.77
ug/l
0.08
190
731
367
5689
0.44
33.33
3.4
4.2
1.42
1.26
mmol/l
3.63
319
5029
361
5621
0.44
33.00
3.8
4.4
1.85
2.31
mu/l
1.30
313
4932
481
6705
0.46
32.00
30.6
21.8
4.02
4.02
mmol/l
0.20
468
6470
481
6698
0.46
31.75
30.7
21.6
137.19
139.64
mmol/l
26.13
469
6468
181
3687
0.38
31.42
3.6
5.4
1.84
4.95
ug/l
2.05
155
3220
473
6580
0.47
30.10
16.6
11.1
28.69
25.38
u/l
1.83
461
6247
400
5869
0.47
28.94
27.1
17.2
80.33
71.54
ml/min/173m2
12.09
351
4895
134
2944
0.37
26.11
3.6
4.7
21.80
21.93
%
0.03
57
1530
271
4435
0.47
24.88
3.3
3.5
15.40
15.03
pmol/l
1.27
234
3858
36
1573
0.20
24.14
1.3
1.6
1.79
1.32
mmol/l
0.71
31
1284
352
5219
0.50
23.64
33.8
21.3
15.13
15.47
%
1.01
346
5102
166
3143
0.43
21.53
1.8
2.1
88.84
91.64
pmol/l
0.29
85
1672
481
6348
0.54
20.62
28.3
18.2
31.57
29.17
mg/l
0.93
460
5222
85
2078
0.35
19.72
2.6
3.3
0.73
0.85
ug/l
0.55
58
1481
134
2548
0.45
16.49
1.7
2.2
71.76
78.03
nmol/l
1.73
112
2185
150
2699
0.48
15.64
2.7
2.7
268.47
166.90
ug/l
2.73
137
2415
89
1917
0.41
14.81
1.5
1.7
18.09
19.43
nmol/l
0.35
80
1624
192
3122
0.52
14.40
4.7
5.3
0.00
0.00
estimate
-0.00
56
598
197
3146
0.54
13.75
3.6
4.0
0.00
0.00
estimate
0.80
58
657
204
3173
0.55
12.74
3.6
3.9
0.00
0.00
estimate
-0.00
55
584
176
2826
0.54
12.13
2.3
2.3
—
—
—
0
0
30
71
4.32
11.79
1.2
1.3
—
—
—
0
0
135
2299
0.52
11.13
3.7
3.7
18.68
9.63
mg/mmol
0.53
84
1476
125
2177
0.51
11.06
3.1
3.1
7.14
7.42
mmol/l
0.37
96
1749
41
135
3.12
10.03
1.3
1.4
4133.19
1447.68
e6/l
1.29
36
88
372
4786
0.65
9.79
4.0
4.0
23.21
15.00
mm/h
11.43
345
4332
122
2070
0.53
9.72
2.4
2.2
3.35
3.11
mg/l
0.55
108
1733
29
78
3.80
9.65
1.2
1.5
12.52
14.23
u/l
0.74
29
70
37
119
3.19
9.41
1.3
1.4
26977.93
36762.25
e6/l
0.29
30
69
162
2425
0.60
7.87
3.9
4.3
—
—
—
0
0
27
89
3.09
6.65
1.1
1.3
12.00
12.29
u/l
0.04
27
82
30
108
2.83
6.36
1.2
1.3
456.62
304.51
u/l
0.55
30
103
105
1672
0.58
6.35
1.6
1.8
415.47
11673287.11
pmol/l
1.06
86
1345
108
1703
0.59
6.28
1.6
1.8
1135.63
1170.70
nmol/l
0.15
84
1249
126
1908
0.61
6.21
2.8
2.9
3536.13
8261.46
umol/l
0.75
106
1589
378
4594
0.72
5.99
3.8
4.8
8.38
1746.26
e6/l
—
8
91
18
49
3.72
5.94
2.2
3.1
—
—
—
0
0
190
2587
0.67
5.64
2.6
3.2
1648.14
2287.34
ng/l
0.55
174
2250
440
3676
1.35
5.11
9.2
6.3
10.88
12.70
umol/l
1.83
430
3472
83
500
1.72
4.90
3.8
3.8
2.75
2.00
mmol/l
0.66
67
374
91
1406
0.61
4.79
4.1
4.3
1.01
1.02
kg/l
0.74
19
225
303
3721
0.73
4.74
4.8
3.2
113.08
56.86
u/l
3.95
277
3379
86
534
1.67
4.55
4.0
3.7
5.36
5.16
kpa
1.09
80
499
253
3156
0.73
4.27
2.4
2.8
—
—
—
0
0
15
413
0.35
4.22
1.3
1.4
—
—
—
0
0
47
825
0.55
4.02
1.2
1.3
15.00
16.22
u/ml
0.05
14
283
127
1759
0.68
3.96
3.7
4.1
0.00
0.01
estimate
0.50
46
559
434
3717
1.30
3.90
14.1
8.5
4.74
4.34
e9/l
2.23
396
3222
52
879
0.57
3.89
1.2
1.3
128.71
38.99
iu/ml
0.86
16
265
170
2221
0.72
3.78
2.1
2.1
215.57
250.12
u/l
0.24
155
2054
23
499
0.45
3.73
1.3
2.3
11.82
11.43
nmol/l
0.09
17
429
368
3112
1.29
3.57
5.4
5.7
20.34
25.30
%
13.14
363
2877
77
500
1.58
3.46
1.5
1.4
—
—
—
0
0
88
1276
0.66
3.45
2.1
2.5
11.32
12.05
umol/l
0.42
82
1179
462
5217
0.79
3.43
13.3
7.7
104.23
82.96
u/l
6.58
454
4839
57
900
0.61
3.28
10.6
8.9
—
—
—
0
0
72
1076
0.64
3.26
1.1
1.2
0.88
1.64
u/ml
1.18
14
265
11
30
3.70
3.09
1.2
1.2
3.14
3.59
mmol/l
0.14
11
24
80
1156
0.67
3.09
2.2
2.5
2.20
2.22
g/l
0.14
70
1064
56
874
0.62
3.08
3.8
4.7
31.10
32.63
%
0.43
42
568
355
3045
1.26
2.95
5.2
5.6
62.73
58.97
%
5.08
349
2824
21
97
2.19
2.78
3.4
3.6
—
—
—
0
0
78
1103
0.68
2.70
2.3
2.6
20.94
22.16
%
0.33
69
937
9
230
0.39
2.70
4.1
1.5
—
—
—
0
0
230
2734
0.79
2.44
3.0
3.4
—
—
—
0
0
381
3349
1.22
2.42
7.1
6.0
1.21
1.21
mmol/l
0.39
370
3002
259
3025
0.81
2.33
3.8
4.3
26.87
70.38
ng/l
3.03
220
2371
411
3673
1.20
2.14
7.6
6.8
1.21
1.21
mmol/l
0.48
346
3080
169
1377
1.27
2.12
1.8
1.9
—
—
—
0
0
27
456
0.58
2.10
2.4
2.9
0.43
0.33
e6/l
0.24
27
445
11
246
0.44
2.04
2.1
1.7
—
—
—
0
0
176
1451
1.26
2.00
5.8
3.3
2.54
2.45
mmol/l
12.04
160
1252
6
16
3.77
1.93
1.7
1.4
1967.00
104.06
nmol/24h
—
6
16
14
276
0.50
1.85
1.7
3.8
50.41
49.18
mg/l
—
9
230
120
953
1.29
1.85
2.7
4.1
363.66
251.51
u/l
3.21
115
882
56
779
0.70
1.82
2.3
2.7
4.25
6.60
ug/l
1.69
49
659
6
154
0.39
1.76
1.0
1.4
—
—
—
0
0
22
125
1.78
1.73
1.2
1.6
—
—
—
0
0
26
156
1.68
1.70
1.5
3.6
78.75
1864.26
u/ml
0.60
20
147
142
1714
0.80
1.69
2.2
2.5
—
—
—
0
0
17
305
0.55
1.69
1.3
1.4
—
68.90
—
0
23
31
197
1.59
1.64
1.4
1.4
—
—
—
0
0
31
197
1.59
1.64
1.4
1.4
—
—
—
0
0
19
105
1.83
1.63
1.4
1.4
—
—
—
0
0
273
2412
1.18
1.55
5.5
3.4
2.37
2.34
mmol/l
3.85
249
2061
26
161
1.63
1.53
2.6
2.5
14.81
15.34
%
—
7
80
18
100
1.81
1.53
2.2
2.0
88.29
89.20
%
0.28
18
100
28
177
1.60
1.53
1.3
1.6
—
—
—
0
0
6
143
0.42
1.52
1.0
1.4
—
—
—
0
0
13
65
2.01
1.49
1.2
1.6
—
—
—
0
0
13
65
2.01
1.49
1.2
1.6
—
—
—
0
0
13
65
2.01
1.49
1.2
1.6
—
—
—
0
0
27
171
1.59
1.47
1.3
1.6
—
—
—
0
0
110
1338
0.80
1.42
1.5
1.7
1.66
1.58
mg/l
0.16
90
1060
353
3204
1.16
1.41
6.0
4.8
32.05
34.23
g/l
9.22
330
2953
205
2344
0.84
1.40
2.8
3.5
58.45
115.57
e6/l
0.78
161
1866
19
111
1.73
1.39
4.9
3.2
59.74
60.99
%
0.09
19
111
139
1646
0.82
1.39
2.5
2.7
7.86
3.83
e6/l
2.64
129
1482
16
89
1.81
1.37
2.3
2.4
—
—
—
0
0
22
345
0.63
1.35
1.5
2.4
—
—
—
0
0
107
1292
0.81
1.30
2.3
3.1
0.80
0.98
e6/l
0.43
51
789
18
106
1.71
1.30
3.6
2.6
5.67
4.70
e9/l
0.68
18
106
7
143
0.49
1.21
1.9
1.6
—
—
—
0
0
17
101
1.69
1.20
1.3
1.5
—
—
—
0
0
27
393
0.68
1.19
4.6
4.2
54.43
46.21
%
1.08
27
388
41
554
0.73
1.19
3.3
3.8
99.69
98.28
ng/l
0.02
35
476
20
125
1.61
1.18
1.4
1.4
—
—
—
0
0
18
110
1.65
1.16
1.3
1.4
—
—
—
0
0
12
207
0.57
1.10
1.0
1.0
—
—
—
0
0
8
41
1.96
1.09
1.6
2.1
—
—
—
0
0
11
59
1.87
1.07
1.4
1.6
—
—
—
0
0
14
82
1.72
1.05
1.4
1.5
—
—
—
0
0
7
34
2.07
1.03
1.6
1.5
—
—
—
0
0
7
34
2.07
1.03
1.6
1.5
—
—
—
0
0
189
2119
0.87
1.01
2.7
3.4
0.91
0.56
e6/l
0.98
147
1662
9
49
1.84
0.98
1.4
1.3
—
—
—
0
0
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
17
258
0.65
0.95
1.4
1.1
133.60
135.13
iu/ml
—
5
94
32
234
1.38
0.94
1.3
1.6
—
—
—
0
0
24
167
1.45
0.92
2.1
2.1
107.09
126.55
g/l
1.04
11
121
130
1486
0.86
0.91
3.5
4.1
151.36
313.70
ng/l
1.15
110
1298
6
29
2.08
0.89
1.2
1.9
—
—
—
0
0
6
29
2.08
0.89
1.2
1.9
—
—
—
0
0
108
1250
0.85
0.88
2.4
3.2
3.19
1.29
e6/l
0.78
53
752
43
548
0.78
0.88
4.0
3.0
53.41
58.82
ml/min/173m2
0.40
17
248
6
30
2.01
0.87
1.2
1.8
—
—
—
0
0
44
552
0.79
0.81
1.2
1.3
—
—
—
0
0
9
148
0.60
0.79
1.3
1.4
—
—
—
0
0
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
0
28
0.00
0.76
0.0
1.3
—
137.51
—
0
28
7
38
1.85
0.73
1.1
1.7
—
—
—
0
0
7
38
1.85
0.73
1.1
1.7
—
—
—
0
0
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
16
109
1.48
0.71
1.1
1.3
—
—
—
0
0
5
26
1.93
0.70
1.8
2.1
455.80
904.23
u/ml
—
5
26
109
959
1.15
0.70
1.8
1.9
—
—
—
0
0
10
61
1.65
0.68
1.2
1.7
—
—
—
0
0
7
42
1.67
0.68
1.3
2.3
—
—
—
0
0
83
718
1.17
0.66
1.7
2.8
65.30
65.78
g/l
0.24
75
638
10
62
1.62
0.65
1.0
1.4
102.80
260.67
pmol/l
—
5
54
43
350
1.24
0.65
1.8
1.9
—
—
—
0
0
17
120
1.42
0.65
1.3
1.6
—
—
—
0
0
17
120
1.42
0.65
1.3
1.6
—
—
—
0
0
5
29
1.73
0.64
2.6
2.8
—
—
—
0
0
5
29
1.73
0.64
2.6
2.8
—
—
—
0
0
14
96
1.46
0.61
1.4
1.4
—
—
—
0
0
39
317
1.24
0.60
1.6
1.8
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
2.0
—
14.66
—
0
14
0
22
0.00
0.59
0.0
1.3
—
150.15
—
0
22
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
23
297
0.77
0.57
4.0
3.2
1.92
1.48
mmol/l
0.78
23
292
44
526
0.83
0.56
2.2
1.7
1.80
1.66
%
0.32
33
422
5
86
0.58
0.56
1.4
1.3
—
—
—
0
0
5
87
0.57
0.56
1.2
1.5
—
—
—
0
0
11
73
1.51
0.56
1.2
1.8
—
—
—
0
0
204
2194
0.91
0.56
2.6
2.5
65.56
59.86
u/l
0.40
180
2017
11
157
0.70
0.51
1.3
1.6
—
—
—
0
0
106
958
1.12
0.49
1.8
1.8
—
—
—
0
0
108
980
1.11
0.47
5.8
6.9
1.73
1.24
mmol/l
0.52
85
762
73
821
0.88
0.46
4.9
3.7
—
—
—
0
0
8
118
0.68
0.46
1.4
1.7
—
—
—
0
0
5
81
0.62
0.46
1.2
1.7
—
—
—
0
0
11
77
1.43
0.45
1.2
1.7
—
—
—
0
0
69
775
0.88
0.43
2.3
3.1
212.73
268.95
ng/l
0.56
63
710
107
977
1.11
0.42
5.7
6.9
5.09
5.09
kpa
0.01
97
925
107
977
1.11
0.42
5.7
6.8
9.96
11.56
kpa
3.97
97
927
113
1035
1.10
0.42
3.7
5.5
1.06
1.04
mmol/l
0.26
105
944
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
9.59
—
0
19
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
5
37
1.35
0.37
1.2
1.1
2.04
2.00
mmol/l
—
5
37
9
124
0.72
0.35
1.1
1.2
—
—
—
0
0
6
88
0.68
0.33
1.2
1.5
—
—
—
0
0
6
88
0.68
0.33
1.3
1.5
—
—
—
0
0
6
89
0.67
0.33
1.3
1.5
—
—
—
0
0
6
89
0.67
0.33
1.2
1.5
—
—
—
0
0
7
97
0.72
0.31
1.0
1.1
—
—
—
0
0
8
109
0.73
0.29
1.1
1.1
—
—
—
0
0
413
4235
0.96
0.26
6.2
5.0
6.83
6.88
mmol/l
0.20
398
4005
71
768
0.92
0.26
3.1
3.7
2.01
2.12
mmol/l
0.07
56
624
9
74
1.22
0.25
1.4
1.3
—
—
—
0
0
13
105
1.24
0.25
1.7
1.5
3.20
5.56
iu/l
—
7
36
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
10
124
0.80
0.21
1.3
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
1737.25
—
0
12
5
43
1.16
0.21
1.8
4.3
—
—
—
0
0
11
89
1.24
0.21
1.2
1.2
18.17
9.00
u/l
0.94
11
66
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
13
0.00
0.21
0.0
2.4
—
205.41
—
0
13
6
50
1.20
0.19
1.5
1.3
68.22
29.29
iu/l
—
6
42
6
52
1.15
0.19
1.2
1.3
—
—
—
0
0
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
10
82
1.22
0.17
1.4
1.5
—
—
—
0
0
10
82
1.22
0.17
1.4
1.5
—
—
—
0
0
19
215
0.88
0.17
1.9
3.0
0.79
0.86
nmol/l
0.31
13
169
6
80
0.75
0.15
1.0
1.0
—
—
—
0
0
7
88
0.79
0.14
1.3
1.5
—
—
—
0
0
34
315
1.08
0.13
1.7
3.3
38.59
13545.07
u/ml
0.87
29
263
28
259
1.08
0.11
4.9
3.5
4.05
4.40
pmol/l
0.78
23
224
51
534
0.95
0.09
2.1
1.7
—
—
—
0
0
59
615
0.96
0.09
2.2
2.6
38.29
34.57
u/l
0.20
51
514
78
807
0.96
0.09
2.8
2.8
14.07
10.28
umol/l
0.63
64
717
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
6
73
0.82
0.07
1.3
1.6
255.33
297.82
mu/l
—
6
65
17
183
0.93
0.06
1.4
1.5
295.45
257.36
ug/g
0.30
11
113
9
103
0.87
0.06
1.2
2.3
—
625.18
—
0
11
58
562
1.03
0.06
1.4
1.6
—
—
—
0
0
51
527
0.97
0.06
6.7
5.9
25.56
24.27
mmol/l
1.21
45
504
27
258
1.05
0.04
1.1
1.9
33.01
36.69
u/l
0.47
21
219
73
746
0.98
0.04
5.3
6.8
11.85
11.89
mmol/l
0.01
65
702
15
140
1.07
0.04
1.2
1.2
578.20
511.57
mg/l
0.29
15
130
204
2058
0.99
0.03
5.4
3.3
47.75
34.21
u/l
0.79
189
1948
15
159
0.94
0.03
1.3
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
321
1.03
0.02
2.0
2.4
0.31
0.36
u/ml
0.50
20
186
21
202
1.04
0.02
2.6
2.3
388.76
84.60
ug/min
—
10
118
20
208
0.96
0.02
1.3
1.3
—
—
—
0
0
11
114
0.96
0.00
1.2
1.1
—
—
—
0
0
16
164
0.98
0.00
1.3
1.2
—
—
—
0
0
11
108
1.02
0.00
1.3
1.3
—
—
—
0
0
26
262
0.99
0.00
1.2
1.2
—
—
—
0
0
385
3848
1.00
0.00
12.2
19.2
1.22
1.41
inr
4.22
101
1066
14
137
1.02
0.00
1.1
1.2
16.80
3.19
u/ml
—
6
19
16
165
0.97
0.00
1.3
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.2
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
5
58
0.86
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
14.71
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
-0.00
1.0
1.3
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
7.65
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
-0.00
1.6
1.2
0.50
0.62
nmol/l
—
7
62
0
7
0.00
-0.00
0.0
4.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
-0.00
0.0
1.2
—
100.44
—
0
9
0
9
0.00
-0.00
0.0
1.3
—
98.89
—
0
9
0
9
0.00
-0.00
0.0
2.8
—
0.67
—
0
9
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: HLP_C3_SCLC – Small cell lung cancer, helper endpoint
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).